About Medoja
Medoja is a company based in Hyderabad (India) founded in 2022 by Yearla Srinivasa Rao. It operates as a B2B and B2C. The company has 1 employees. Medoja offers products and services including Nanohydroxyapatite, Hydroxyapatite, Resorbable Blast Media, Beta-TCP, and MedoSirā Bone Graft. Medoja operates in a competitive market with competitors including Curapath, Flashpoint Therapeutics, Biocydex, Vim Meditech and Magle Group, among others.
- Headquarter Hyderabad, India
- Employees 1 as on
- Founders Yearla Srinivasa Rao
-
Sectors
ConsumerHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Medoja Health Private Limited
- Date of Incorporation 23 Oct, 2020
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
1
as on
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Medoja
Medoja offers a comprehensive portfolio of products and services, including Nanohydroxyapatite, Hydroxyapatite, Resorbable Blast Media, Beta-TCP, and MedoSirā Bone Graft.
Biocompatible ingredient for toothpaste to enhance remineralization and oral health.
Material for orthopedic implants promoting osseointegration and bone growth.
Solution for dental implants to minimize residual particles and improve integration.
Biocompatible substance for dental research and regenerative applications.
Angiogenic graft for bone regeneration in medical procedures.
Funding Insights of Medoja
Detailed funding history for Medoja
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Medoja
Investment portfolio details for Medoja
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Medoja
Detailed financials for Medoja
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medoja Comparisons
Peer comparison for Medoja
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Medoja
Medoja operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Curapath, Flashpoint Therapeutics, Biocydex, Vim Meditech and Magle Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of drug delivery systems for therapeutic purposes
|
|
| Locked | Locked | Locked |
Flashpoint Therapeutics is developing nanotherapeutic candidates that can deliver precise RNA, DNA, and peptide payloads to specific cells at the right time.
|
|
| Locked | Locked | Locked |
Preclinical drug discovery, formulation and drug delivery R&D services
|
|
| Locked | Locked | Locked |
Specializes in developing and manufacturing innovative parenteral drug delivery systems and sterile injectables.
|
|
| Locked | Locked | Locked |
Develops medical technologies for pharmaceuticals, therapeutics, and biopolymers.
|
|
| Locked | Locked | Locked |
Targeted chemotherapy, vaccines, and gene therapy are delivered via nanotechnology.
|
Detailed competitors of Medoja
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medoja
Complete news archive for Medoja
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medoja
Medoja was founded in 2022.
Medoja is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of the latest available data, the latest employee count at Medoja is 1.
Medoja Bio Private Limited focuses on developing and manufacturing environment-friendly biomaterials and nanobiomaterials. They offer products like nanohydroxyapatite for toothpaste and hydroxyapatite for medical implants, emphasizing quality control and RD. Based in Hyderabad, India, they provide customizable solutions for sectors including drug delivery and cosmetics, serving industries through B2B and B2C channels.
Medoja's top competitors include Flashpoint Therapeutics, Curapath and DNA Nanobots.
Medoja offers Nanohydroxyapatite, Hydroxyapatite, Resorbable Blast Media, Beta-TCP, and MedoSirā Bone Graft.